MULTIFOCAL MOTOR NEUROPATHY (MMN)
Clinical trials for MULTIFOCAL MOTOR NEUROPATHY (MMN) explained in plain language.
Never miss a new study
Get alerted when new MULTIFOCAL MOTOR NEUROPATHY (MMN) trials appear
Sign up with your email to follow new studies for MULTIFOCAL MOTOR NEUROPATHY (MMN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended trial tests nerve disease Treatment's staying power
Disease control OngoingThis study continues testing an experimental drug called ARGX-117 in adults with multifocal motor neuropathy (MMN), a rare condition that causes muscle weakness. It follows 51 participants from a previous trial to check the drug's long-term safety and whether it helps maintain mu…
Matched conditions: MULTIFOCAL MOTOR NEUROPATHY (MMN)
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New treatment tested for rare nerve diseases in japan
Disease control OngoingThis study is testing a drug called TAK-771 to see if it can safely control symptoms in Japanese adults with two rare, long-term nerve disorders: CIDP and MMN. Participants, who must already be responding to a standard treatment, will receive TAK-771 for up to 45 months. The main…
Matched conditions: MULTIFOCAL MOTOR NEUROPATHY (MMN)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC